| drug name | Calcium Hydroxylapatite (Radiesse) |
| classification | Injectable dermal filler |
| pharmacokinetics | Calcium hydroxylapatite is a biocompatible material. Upon injection, it is gradually integrated into the surrounding tissue over several months. The body does not absorb or metabolize the calcium hydroxylapatite. Resorption is slow and gradual, leading to a sustained volumizing effect. |
| suggested dosage | Dosage is determined by the treating physician based on the individual patient's needs and the specific area requiring treatment. No standardized dosage exists. The procedure typically involves multiple smaller injections to minimize tissue damage. Precise volumes and injection sites are tailored to the aesthetic goals and clinical considerations. |
| indications | Radiesse is used for improving facial volume loss, correcting facial wrinkles and folds, restoring facial contours, and creating a more youthful appearance. |
| safety in pregnancy | Limited data regarding safety during pregnancy. The use of Radiesse during pregnancy is not recommended unless the potential benefits outweigh the potential risks to the developing fetus. Consult with a healthcare professional before considering use during pregnancy. |
| safety in breastfeeding | Limited data regarding safety during breastfeeding. The use of Radiesse is not recommended while breastfeeding as the safety profile in this population is not established. |
| side effects | | 1 | Swelling | | 2 | Pain | | 3 | Redness | | 4 | Bruising | | 5 | Nodules | | 6 | Inflammation | | 7 | Erythema | | 8 | Infection (rare) | | 9 | Numbness | | 10 | Irritation | | 11 | Hematomas | | 12 | Asymmetry | | 13 | Allergic reactions (rare) |
|
| alternatives | | 1 | | alternative name | Hyaluronic acid fillers | | alternative description | These fillers are more commonly used and have a broader range of formulations and indications. |
| | 2 | | alternative name | Poly-L-lactic acid fillers | | alternative description | Longer-lasting results compared to HA fillers but are often more expensive. |
|
|
| contraindications | | 1 | Known hypersensitivity or allergy to calcium hydroxylapatite or any component of the formulation | | 2 | Active infections at the injection site | | 3 | Uncontrolled bleeding disorders | | 4 | Pregnancy | | 5 | Breastfeeding | | 6 | Unstable medical conditions | | 7 | Pre-existing medical conditions in the targeted facial areas |
|
| interactions | No specific drug interactions are known. However, concurrent use of anticoagulants or other medications that affect blood clotting may increase the risk of bruising or bleeding. Consult with the prescribing physician about all medications. |
| warnings and precautions | | 1 | The injection procedure should be performed by a qualified and experienced medical professional. | | 2 | Proper patient selection and risk assessment are crucial. | | 3 | Potential for uneven results or complications if not administered correctly. | | 4 | Careful monitoring and management of side effects are essential. | | 5 | Long-term effects or changes in facial anatomy are not fully established. |
|
| additional information | Individual responses to Radiesse vary. Consult with a qualified aesthetic physician to determine suitability and expectations. A discussion about realistic aesthetic goals is critical before treatment. Follow post-treatment care instructions diligently to minimize complications. |
| patient details | |
